ABBV
ABBVIE INC.
Latest price
As of Oct 26, 2026, 6:30 PM EDT · Market data by Massive
Market cap
$504.8B
Volume
4.5M
Previous close
$285.64
Day range
$285.18 – $289.59
Listed
Dec 10, 2012
Coverage
4 articles
Price performance
Recent trading
Newsroom
Latest ABBV coverage
Abbvie’s $1 Billion Gilgamesh Gambit: The Deal That Could Rewrite Its Future!
AbbVie’s recent confirmation that it’s in talks to acquire Gilgamesh Pharmaceuticals for roughly $1 billion underscores its unrelenting push to replenish growth after Humira’s patent cliff.
Arcutis Biotherapeutics Surges Amid Takeover Speculation: Why Large Pharma Should Pay Attention!
According to a Betaville "uncooked" alert, an unidentified European pharmaceutical company is reportedly exploring a bid for Arcutis Biotherapeutics.
ABBV AbbVie Inc Continues To Impress (NYSE:ABBV)
Intro & History on ABBV (NYSE:ABBV) : In the biotech and medical marijuana arena, we think that ABBV AbbVie Inc. (NYSE ABBV) is an interesting and well known stock to keep an eye on. ABBV is a pharmaceutical development, discovery, manufacturing and sales firm based in Illinois near Chicago, and traded on NYSE and they...
What's Going On With Biotech Stocks 2018? Here's what we know…
Intro & History on ABBV (NYSE:ABBV) : In the biotech and medical marijuana arena, we think that ABBV AbbVie Inc. (NYSE ABBV) is an interesting and well known stock to keep an eye on. ABBV is a pharmaceutical development, discovery, manufacturing and sales firm based in Illinois near Chicago, and… We think Cara Therapeutics...